Published in Eur Arch Otorhinolaryngol on June 01, 2010
Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications. Eur Arch Otorhinolaryngol (2013) 0.91
Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma. Am J Transl Res (2014) 0.88
Prognostic biological features in neck dissection specimens. Eur Arch Otorhinolaryngol (2012) 0.79
Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC). Eur Arch Otorhinolaryngol (2015) 0.76
Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. Int J Clin Oncol (2014) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
High density synthetic oligonucleotide arrays. Nat Genet (1999) 29.99
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
A molecular signature of metastasis in primary solid tumors. Nat Genet (2002) 21.36
Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet (2005) 17.75
Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst (2003) 9.68
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell (2004) 8.06
Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature (2008) 4.24
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell (2004) 3.91
Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res (2009) 3.86
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg (2002) 3.37
Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J Natl Cancer Inst (2005) 3.26
Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics (2004) 3.14
An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet (2005) 3.04
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A (2005) 2.96
Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med (1996) 2.95
Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res (2008) 2.81
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene (2006) 2.56
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol (2006) 2.48
One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res (2007) 2.36
Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene (2004) 2.19
Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem (2005) 2.05
Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res (2006) 2.05
Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A (1994) 1.81
Nucleic acid-based methods for the detection of cancer. Science (1997) 1.80
Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene (2005) 1.78
Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol (2006) 1.76
Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis? Eur J Cancer (2007) 1.70
Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol (2006) 1.67
p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev (2002) 1.57
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46
Genomic screening of head and neck cancer and its implications for therapy planning. Eur Arch Otorhinolaryngol (2006) 1.45
Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck (2005) 1.45
EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res (2000) 1.44
P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck (2003) 1.40
Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet (1997) 1.37
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37
Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol (2006) 1.27
Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res (2006) 1.27
Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res (2004) 1.24
Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.23
Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.23
Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol (2000) 1.20
Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis. Cell Oncol (2009) 1.10
Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res (2005) 1.10
Does tumor depth affect nodal upstaging in squamous cell carcinoma of the head and neck? Laryngoscope (2008) 1.08
Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg (1994) 1.07
Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.07
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol (2002) 1.04
Pathology of the N0 neck. Br J Oral Maxillofac Surg (1999) 1.02
Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol (2009) 1.02
Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg (1997) 0.99
Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 0.98
Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Clin Cancer Res (2004) 0.96
Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer (2003) 0.94
The molecular outlook. Nature (2002) 0.94
Shoulder complaints after nerve sparing neck dissections. Int J Oral Maxillofac Surg (2004) 0.93
Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol (2003) 0.93
Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec (2004) 0.90
New molecular diagnostic methods in head and neck cancer. Head Neck (2005) 0.90
Screening for oral precancer with noninvasive genetic cytology. Cancer Prev Res (Phila) (2009) 0.90
Molecular signatures of metastasis in head and neck cancer. Head Neck (2008) 0.89
Immunohistochemical detection of cervical lymph node micrometastases from T2N0 tongue cancer. Acta Otolaryngol (2005) 0.89
Level IIb lymph nodes metastasis in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: a molecular-based study. Laryngoscope (2005) 0.88
Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer? Head Neck (2008) 0.87
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma. J Clin Oncol (2007) 0.86
Molecular assessment of neck dissections supports preserving level IIB lymph nodes in selective neck dissection for laryngeal squamous cell carcinoma with a clinically negative neck. ORL J Otorhinolaryngol Relat Spec (2006) 0.86
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol (2004) 0.86
Medicine: profile of a tumour. Nature (2004) 0.85
Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol (2004) 0.85
Site-specific molecular signatures predict aggressive disease in HNSCC. Head Neck Pathol (2008) 0.84
Genomic medicine. Gene expression tests foretell breast cancer's future. Science (2004) 0.84
Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res (2003) 0.84
Significant invasion depth of early oral tongue cancer originated from the lateral border to predict regional metastases and prognosis. Int J Oral Maxillofac Surg (2009) 0.83
Evolving 'omics' technologies for diagnostics of head and neck cancer. Brief Funct Genomic Proteomic (2009) 0.82
Clinicopathological factors related to cervical lymph node metastasis in a patient with carcinoma of the oral floor. Acta Otolaryngol Suppl (2007) 0.81
Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge? J Clin Oncol (2008) 0.80
Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma. Head Neck (2005) 0.78
Molecular markers of micrometastasis in oral cavity carcinomas. Otolaryngol Head Neck Surg (2009) 0.75
The molecular biology of head and neck cancer. Nat Rev Cancer (2010) 9.84
Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer (2008) 7.99
Dissecting the metastatic cascade. Nat Rev Cancer (2004) 6.32
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res (2003) 5.04
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer (2007) 4.29
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res (2006) 3.32
The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol (2008) 2.58
Paragangliomas of the head and neck. Oral Oncol (2004) 2.47
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res (2010) 1.97
Neuroendocrine neoplasms of the larynx: an overview. Head Neck (2009) 1.92
Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol (2006) 1.70
Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg (2008) 1.68
Thyroglossal duct cyst: personal experience and literature review. Auris Nasus Larynx (2007) 1.57
Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol (2012) 1.55
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol (2012) 1.43
An outline of the history of head and neck oncology. Oral Oncol (2007) 1.42
Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck (2002) 1.41
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck? J Am Coll Surg (2005) 1.39
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol (2002) 1.38
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37
Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst (2008) 1.36
Aspergillosis--and a misleading sensitivity result. Lancet (2007) 1.36
A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med (2004) 1.36
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck (2010) 1.34
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34
Advances and applications of oral cancer basic research. Oral Oncol (2011) 1.33
Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer (2012) 1.31
Management of sarcomas of the head and neck in adults. Oral Oncol (2003) 1.31
Evidence-based review of treatment options for patients with glottic cancer. Head Neck (2011) 1.30
Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol (2009) 1.29
Neck disease and distant metastases. Oral Oncol (2003) 1.27
Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol (2010) 1.26
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res (2004) 1.24
CGHMultiArray: exact P-values for multi-array comparative genomic hybridization data. Bioinformatics (2005) 1.23
Human papillomavirus infections in laryngeal cancer. Head Neck (2011) 1.22
Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol (2002) 1.20
Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol (2005) 1.20
Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review. Head Neck (2010) 1.20
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin Cancer Res (2009) 1.19
Surgical margins in head and neck cancer: a contemporary review. Head Neck (2012) 1.19
Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck (2008) 1.18
Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res (2004) 1.18
Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol (2002) 1.16
Management of nasal bone fractures. Am J Otolaryngol (2005) 1.16
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. Eur J Cancer (2009) 1.14
Aggressive variants of papillary thyroid carcinoma. Head Neck (2010) 1.13
Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol (2007) 1.13
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13